Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm
Arteriosclerosis, Thrombosis, and Vascular Biology · 2025
DOI: 10.1161/atvbaha.124.322350 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Aisah A Aubdool und 17 weiteren Autor:innen. Beteiligte Einrichtung: William Harvey Research Institute, Faculty of Medicine and Dentistry, Barts & The London Hospitals, Queen Mary University of London, United Kingdom (…. Hauptthemen laut MEDLINE: Natriuretic Peptide, C-Type, Fibroblasts, Aortic Aneurysm, Abdominal, Aortic Aneurysm, Thoracic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Thoracic (TAA) and abdominal (AAA) aortic aneurysm are life-threatening diseases characterized by dilation, inflammation, and structural weakness; development of pharmacological therapies is desperately needed. CNP (C-type natriuretic peptide) plays a key role in vascular homeostasis, mediating vasodilator, anti-inflammatory, and antiatherogenic actions. Since such processes drive AA, we determined the role of endogenous CNP in offsetting pathogenesis. METHODS: Tissue from patients with AA was analyzed to determine the consequences on CNP signaling. Ascending and suprarenal aortic diameters were assessed at baseline and following Ang II (angiotensin II; 1.44 mg/kg per day) infusion in wild-type, endothelium-restricted (ecCNP −/− ), fibroblast-restricted (fbCNP −/− ), global CNP (gbCNP −/− ), or global NPR-C −/− mice infected with an adeno-associated virus expressing a proprotein convertase subtilisin/kexin type 9 gain-of-function mutation or backcrossed to an apoE −/− background. At 28 days, aortas were harvested for RT-qPCR (quantitative reverse transcription polymerase chain reaction) and histological analyses. CNP (0.2 mg/kg per day) was infused to rescue any adverse phenotype. RESULTS: Aneurysmal tissue from patients with TAA and AAA revealed that CNP and NPR-C (natriuretic peptide receptor-C) expression were overtly perturbed. ecCNP −/− , fbCNP −/− , and gbCNP −/− mice exhibited an aggravated phenotype compared to wild-type animals in both ascending and suprarenal aortas, exemplified by greater dilation, fibrosis, elastin degradation, and macrophage infiltration. CNP and NPR-C expression was also dysregulated in murine thoracic AA and abdominal AA, accompanied by increased accumulation of mRNA encoding markers of inflammation, extracellular matrix remodeling/calcification, fibrosis, and apoptosis. CNP also prevented activation of isolated macrophages and vascular smooth muscle cells. An essentially identical phenotype was observed in NPR-C −/− mice and while administration of CNP protected against disease severity in wild-type animals, this phenotypic rescue was not apparent in NPR-C −/− mice. CONCLUSIONS: Endothelium- and fibroblast-derived CNP, via NPR-C activation, plays important roles in attenuating AA formation by preserving aortic structure and function. Therapeutic strategies aimed at mimicking CNP bioactivity hold potential to reduce the need for surgical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- William Harvey Research Institute, Faculty of Medicine and Dentistry, Barts & The London Hospitals, Queen Mary University of London, United Kingdom (A.A.A., A.J.M., C.P.-T., R.S.B., J.S.S., M.T.S., K.J., A.K.P., A.J.H.).
- Division of Surgery and Interventional Science, University College London and Royal Free London NHS Foundation Trust, United Kingdom (J.C.T.).
- Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX (Y.L., H.G.V., Y.H.S., S.A.L.).
- Geisinger Research Institute and Heart & Vascular Institute, Geisinger Medical Center, Danville, PA (S.A.L.).
- Université Côte d'Azur, INSERM U1065, France (J.R.).
- Division of Cardiovascular Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, United Kingdom (Z.M.).
ORCID-Profile: Aisah A Aubdool, Amie J Moyes, Cristina Perez-Ternero, Reshma S Baliga, M Taaha Syed, Janice C Tsui, Yanming Li, Ying H Shen, Ziad Mallat, Hong S Lu, Alan Daugherty, Adrian J Hobbs
Förderung
- NHLBI NIH HHS
Zitieren
APA
Aubdool, A. A., Moyes, A. J., Perez-Ternero, C., Baliga, R. S., Sanghera, J. S., Syed, M. T., Jaigirdar, K., Panesar, A. K., Tsui, J. C., Li, Y., Vasquez, H. G., Shen, Y. H., LeMaire, S. A., Raffort, J., Mallat, Z., Lu, H. S., Daugherty, A., & Hobbs, A. J. (2025). Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.322350
Vancouver
Aubdool AA, Moyes AJ, Perez-Ternero C, Baliga RS, Sanghera JS, Syed MT, et al. Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.124.322350
BibTeX
@article{Aubdool2025,
author = {Aubdool, Aisah A and Moyes, Amie J and Perez-Ternero, Cristina and Baliga, Reshma S and Sanghera, Jaspinder Singh and Syed, M Taaha and Jaigirdar, Kareemah and Panesar, Anmolpreet K and Tsui, Janice C and Li, Yanming and Vasquez, Hernan G and Shen, Ying H and LeMaire, Scott A and Raffort, Juliette and Mallat, Ziad and Lu, Hong S and Daugherty, Alan and Hobbs, Adrian J},
title = {Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2025},
doi = {10.1161/atvbaha.124.322350}
}
EUVIMED